MDB Capital Holdings, LLC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MDB Capital Holdings, LLC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.25M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($6.97M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($5.31M) | Mar 29, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.91M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.16M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.00M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.22M | Mar 29, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $1.47M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $528.2K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $348.1K | Mar 29, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.68M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($9.04M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($7.13M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($6.57M) | Mar 29, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $438.8K | Mar 29, 2024 |
| FY2023 | Dec 31, 2022 | $193.3K | Mar 29, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.74M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $71.98M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $42.99M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $25.70M | Mar 29, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.90M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.67M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.59M | Mar 29, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.69M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $70.16M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $37.31M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $22.64M | Mar 29, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.80M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.44M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($12.09M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($5.12M) | Mar 29, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.22M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $20.44M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.11M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.95M | Mar 29, 2024 |